Implementing Regulation (EU) 2019/1589 extended the approval periods of the active substances amidosulfuron, bifenox, clofentezine, dicamba, difenoconazole, diflufenican, fenoxaprop-P, fenpropidin, lenacil, nicosulfuron, picloram and triflusulfuron until 31 December 2020.
Recital 4, Regulation (EU) 2020/1511
In forcesince 16 Oct 2020